The Efficiency of Ace-Inhibitors in the Treatment of Mild Hypertension

References

• Andrén L., Karlberg B., Öhman P., Svensson A., Asplund J. & Hansson L. Captopril and atenolol combined with hydrochlorothiazide in essential hypertension. Br. J. Clin. Pharmac., 14: 107S 1982.
   Google Scholar
• Andrén L., Svensson A. & Hansson L. Captopril and atenolol in essential hypertension. Acta Med. Scand., Suppl. 677: 115 1983.
   Google Scholar
• Andrén L., Weiner L., Svensson A. & Hansson L. Enalapril with either a "very low" or "low" dose of hydrochlorothiazide is equally effective in essential hypertension. A double-blind trial in 100 hypertensive patients. J. Hypertension 1 (suppl. 2) 384, 1983.
   Google Scholar
• Atkinson A.B., Lever A.F., Brown J.J. & Robertson J.I.S. Combined treatment of severe intractable hypertension with captopril and diuretic. Lancet 2: 105 1980.
   Google Scholar
• Case D.B., Atlas S.A., Laragh J.H., Sullivan P.A. & Sealey J.E. Use of first-dose response or plasma renin activity to predict the long-term effect of captopril: Identification of triphasic pattern of blood pressure response. J. Cardiovasc. Pharmacol. Vol. 2: 339 1980.
   Google Scholar
• Cody R.J., Laragh J.H., Atlas S.A. & Case D.B. Converting enzyme inhibition to identify and treat reninmediated or sodium-volume releated forms of increased peripheral resistance in hypertension and in congestive heart failure. J. Hypertension 1 (suppl. 1): 77 1983.
   Google Scholar
• Dollery C.T. Safety and efficacy of enalapril. Summing up the evidence. J. Hypertension 1 (suppl. 1) 155, 1983.
   Google Scholar
• Drayer J.I.M. & Weber M.A. Monotherapy of essential hypertension with a converting-enzyme inhibitor. Hypertension 5 (suppl. III): III-108, 1983.
   Google Scholar
• Gomez H.J., Cirillo V.J. & Jones K.H. The clinical pharmacology of enalapril. J. Hypertension 1 (suppl. 1): 65, 1983.
   Google Scholar
• Groel J.T., Tadros S.S., Dreslinski G.R. & Jenkins A.C. Long term antihypertensive therapy with captopril. Hypertension 5 (suppl. III): III-145, 1983.
   Google Scholar
• Hodsman G.P., Isles C.G., Murray G.D., Usherwood T.P., Webb D.J. & Robertson J.I.S. Factors related to first dose hypotensive effect of captopril: prediction and treatment. Br. Med. J. 286:832, 1983.
   Google Scholar
• Hodsman G.P. & Robertson J.I.S. Captopril: five years on. Br Med. J. 287:851, 1983.
   Google Scholar
• Hodsman G.P., Zabludowski J.R., Zoccali C., Fraser R., Morton J.J., Murray G.D. & Robertson J.I.S. Enalapril (MK421) and its lysine analogue (MK521): A comparison of acute and chronic effects on blood pressure, reninangiotensin system and sodium exretion in normal man. Br. J. clin. Pharmac. 17: 233, 1984.
   Google Scholar
• Holland O.B., La Von Kuhnert R.N., Campbell W.B. & Andersson R.J. Synergistic effect of captopril with hydrochlorothiazide for the treatment of low-renin hypertensive black patients. Hypertension 5: 235, 1983.
   Google Scholar
• Ibsen H., Leth A., Hollnagel H. Kappelgaard A.M., Damkjær Nielsen M., Christensen N.J. & Giese J. Renin-angiotensin system in mild essential hypertension. The functional significance of angiotensin II in untreated and in thiazide-treated hypertensive patients. Acta Med. Scand 205: 547, 1979.
   Google Scholar
• Kaneko Y., Yamada K., Ikeda M. & Omae T. Antihypertensive effect of low-dose captopril in mild-to-moderate essentia hypertension. Proceedings of the Ninth scientific meeting of the international society of hypertension, 1982.
   Google Scholar
• Karlberg B.E., Asplund J. Nilsson O.R., Wettre S. & Öhman K.P. Captopril, an orally active converting enzyme inhibitor, in the treatment of primary hypertension. Acta Med. Scand. 209: 245, 1981.
   Google Scholar
• McGregor G.A., Markandu N.D., Banks R.A., Bayliss J., Roulston J.E. & Jones J.C. Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranalol. Br. Med. J. 284: 693, 1982.
   Google Scholar
• Multiple risk factor intervention trial research group: Multiple risk factor intervention trial. JAMA 248: 1465, 1982.
   Google Scholar
• Rasmussen S., Damkjær Nielsen M., Ibsen H., Leth A. & Giese J. The renin-angiotensin system during converting enzyme inhibition with captopril in patients with severe treatment-resistant hypertension. Eur. J. Clin. Invest. 14: 30, 1984.
   Google Scholar
• Rasmussen S., Leth A., Ibsen H., Damkjær Nielsen M., Nielsen F. & Giese J. Captopril in mild and moderate essential hypertension: Physiological and biochemical monitoring. Acta Med. Scand. suppl, 677: 105, 1983.
   Google Scholar
• Veterans administration co-operative study group on antihypertensive agents. Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide. Br. J. Clin. Pharm. 14 (suppl. 2): 975, 1982.
   Google Scholar
• Veterans administration co-operative study group on antihypertensive agents. Low-dose captopril for the treatment of mild to moderate hypertension. Hypertension 5 (suppl. III): III-139, 1983.
   Google Scholar
• Vlasses P.H., Koffer H., Ferguson R.K., Green P.J. & Mc Elwain G.E. Captopril withdrawal after chronic therapy. Clin. Exper. Hypertension 3: 929, 1981.
   Google Scholar
• Weinberger M.H. Influence of an angiotensin converting-enzyme inhibitor on diuretic-induced metabolic effects in hypertension. Hypertension 5 (suppl. III): III-132, 1983.
   Google Scholar
• WHO/ISH Mild Hypertension Liaison Committee. Trials for the treatment of mild hypertension. Lancet I: 149, 1982.
   Google Scholar